Related Experiment Videos
Hypoglycemia: a complication of diabetes therapy in children
1Department of Pediatrics, Division of Pediatric Endocrinology, Metabolism, and Diabetes Mellitus, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. beckerd@chplink.chp.edu
Insights
Hypoglycemia is a common complication for children with type 1 diabetes on insulin. Tighter glucose control and younger age increase hypoglycemia risk, but poor control doesn't prevent severe episodes.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Disorders
Background:
- Hypoglycemia is the most frequent acute complication in pediatric patients with type 1 diabetes mellitus (T1DM) requiring insulin therapy.
- Studies indicate a correlation between stricter glycemic control and younger age with increased hypoglycemia incidence.
- Notably, even individuals with poor metabolic control (high HbA1c) are susceptible to severe hypoglycemic events.
Purpose of the Study:
- To review current and controversial aspects of hypoglycemia in pediatric T1DM.
- To examine the prevalence, etiology, consequences, and prevention of hypoglycemia in this population.
- To explore potential mechanisms behind varied responses to hypoglycemia.
Main Methods:
- Literature review focusing on pediatric type 1 diabetes.
- Analysis of studies on hypoglycemia prevalence, causes, and outcomes.
- Discussion of preventive strategies and underlying physiological responses.
Main Results:
- Hypoglycemia frequency is linked to glycemic control intensity and patient age.
- Severe hypoglycemia can occur across the spectrum of metabolic control.
- Variability in hypoglycemia response suggests complex underlying mechanisms.
Conclusions:
- Hypoglycemia management in pediatric T1DM requires careful consideration of glycemic targets and patient factors.
- Further research is needed to understand individual response variability and optimize prevention.
- Balancing intensive glycemic control with hypoglycemia risk is crucial for T1DM management in children.
Abstract:
Hypoglycemia is the most common acute complication in insulin-treated type 1 diabetic patients. Most surveys have demonstrated that the tighter the glycemic control, and the younger the patient, the greater the frequency of both mild and severe hypoglycemia. However, people in poor metabolic control, with high glycosylated hemoglobin levels, are not protected from experiencing severe hypoglycemia. Focusing on the pediatric population, we review new or controversial issues surrounding the prevalence of hypoglycemia, its causes, its consequences and preventive strategies, and discuss possible mechanisms underlying the variability of responses to hypoglycemia.